• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Dr. Reddy's Laboratories Limited — Updates, 13-03-2026: General Updates

    13-03-2026 | 06:40 pm

    Dr. Reddy's subsidiary's partnered drug, Eftilagimod Alfa, hit a roadblock. Its Phase III trial for lung cancer was halted after an independent review *suggested* discontinuation due to futility. Dr. Reddy's SA made only an upfront payment, limiting exposure while assessing next steps.

    No comments yet. Be the first to comment!

    All announcements from Dr. Reddy's Laboratories Limited